Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 134

1.

Anti-Cancer Effects of a Neutral Triterpene Fraction from Ganoderma lucidum and its Active Constituents on SW620 Human Colorectal Cancer Cells.

Li P, Liu L, Huang S, Zhang Y, Xu J, Zhang Z.

Anticancer Agents Med Chem. 2019 Oct 14. doi: 10.2174/1871520619666191015102442. [Epub ahead of print]

PMID:
31749435
2.

Ganoderma Lucidum induces oxidative DNA damage and enhances the effect of 5-Fluorouracil in colorectal cancer in vitro and in vivo.

Opattova A, Horak J, Vodenkova S, Kostovcikova K, Cumova A, Macinga P, Galanova N, Rejhova A, Vodickova L, Kozics K, Turnovcova K, Hucl T, Sliva D, Vodicka P.

Mutat Res. 2019 Sep;845:403065. doi: 10.1016/j.mrgentox.2019.06.001. Epub 2019 Jun 3.

PMID:
31561886
3.

Autophagic flux disruption contributes to Ganoderma lucidum polysaccharide-induced apoptosis in human colorectal cancer cells via MAPK/ERK activation.

Pan H, Wang Y, Na K, Wang Y, Wang L, Li Z, Guo C, Guo D, Wang X.

Cell Death Dis. 2019 Jun 11;10(6):456. doi: 10.1038/s41419-019-1653-7.

4.

Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y.

Liang C, Tian D, Liu Y, Li H, Zhu J, Li M, Xin M, Xia J.

Eur J Med Chem. 2019 Jul 15;174:130-141. doi: 10.1016/j.ejmech.2019.04.039. Epub 2019 Apr 20. Review.

PMID:
31035236
5.

Improved antitumor activity of cisplatin combined with Ganoderma lucidum polysaccharides in U14 cervical carcinoma-bearing mice.

Zhu J, Xu J, Jiang LL, Huang JQ, Yan JY, Chen YW, Yang Q.

Kaohsiung J Med Sci. 2019 Apr;35(4):222-229. doi: 10.1002/kjm2.12020. Epub 2019 Apr 8.

6.

Comparative and chemometric analysis of correlations between the chemical fingerprints and anti-proliferative activities of ganoderic acids from three Ganoderma species.

Zhang C, Fu D, Chen G, Guo M.

Phytochem Anal. 2019 Jul;30(4):474-480. doi: 10.1002/pca.2830. Epub 2019 Apr 1.

PMID:
30932273
7.

Antiproliferative Effects of a Triterpene-Enriched Extract from Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), on Human Lung Cancer Cells.

Zolj S, Smith MP, Goines JC, Ali TS, Huff MO, Robinson DL, Lau JM.

Int J Med Mushrooms. 2018;20(12):1173-1183. doi: 10.1615/IntJMedMushrooms.2018028823.

PMID:
30806298
8.

Phytochemical composition, antioxidant and antiproliferative activities and effects on nuclear DNA of ethanolic extract from an Italian mycelial isolate of Ganoderma lucidum.

Saltarelli R, Palma F, Gioacchini AM, Calcabrini C, Mancini U, De Bellis R, Stocchi V, Potenza L.

J Ethnopharmacol. 2019 Mar 1;231:464-473. doi: 10.1016/j.jep.2018.11.041. Epub 2018 Dec 1.

PMID:
30513345
9.

Antioxidant potential of ganoderic acid in Notch-1 protein in neuroblastoma.

Gill BS, Navgeet, Kumar S.

Mol Cell Biochem. 2019 Jun;456(1-2):1-14. doi: 10.1007/s11010-018-3485-7. Epub 2018 Dec 3.

PMID:
30511344
10.

Ganoderma tsugae induced ROS-independent apoptosis and cytoprotective autophagy in human chronic myeloid leukemia cells.

Hseu YC, Shen YC, Kao MC, Mathew DC, Karuppaiya P, Li ML, Yang HL.

Food Chem Toxicol. 2019 Feb;124:30-44. doi: 10.1016/j.fct.2018.11.043. Epub 2018 Nov 19.

PMID:
30465897
11.

Effective cancer immunotherapy by Ganoderma lucidum polysaccharide-gold nanocomposites through dendritic cell activation and memory T cell response.

Zhang S, Pang G, Chen C, Qin J, Yu H, Liu Y, Zhang X, Song Z, Zhao J, Wang F, Wang Y, Zhang LW.

Carbohydr Polym. 2019 Feb 1;205:192-202. doi: 10.1016/j.carbpol.2018.10.028. Epub 2018 Oct 13.

PMID:
30446095
12.

Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells.

Wu K, Na K, Chen D, Wang Y, Pan H, Wang X.

Int J Oncol. 2018 Dec;53(6):2356-2368. doi: 10.3892/ijo.2018.4578. Epub 2018 Sep 28.

13.

Antitumor Activity of Extract From the Sporoderm-Breaking Spore of Ganoderma lucidum: Restoration on Exhausted Cytotoxic T Cell With Gut Microbiota Remodeling.

Su J, Su L, Li D, Shuai O, Zhang Y, Liang H, Jiao C, Xu Z, Lai Y, Xie Y.

Front Immunol. 2018 Jul 31;9:1765. doi: 10.3389/fimmu.2018.01765. eCollection 2018.

14.

Tumor inhibitory effects of intravesical Ganoderma lucidum instillation in the syngeneic orthotopic MB49/C57 bladder cancer mice model.

Yuen JWM, Mak DSY, Chan ES, Gohel MDI, Ng CF.

J Ethnopharmacol. 2018 Sep 15;223:113-121. doi: 10.1016/j.jep.2018.05.020. Epub 2018 May 18.

PMID:
29783018
15.

Comprehensive comparison of polysaccharides from Ganoderma lucidum and G. sinense: chemical, antitumor, immunomodulating and gut-microbiota modulatory properties.

Li LF, Liu HB, Zhang QW, Li ZP, Wong TL, Fung HY, Zhang JX, Bai SP, Lu AP, Han QB.

Sci Rep. 2018 Apr 18;8(1):6172. doi: 10.1038/s41598-018-22885-7.

16.

Antitumor and Immunomodulatory Activities of Ganoderma lucidum Polysaccharides in Glioma-Bearing Rats.

Wang C, Shi S, Chen Q, Lin S, Wang R, Wang S, Chen C.

Integr Cancer Ther. 2018 Sep;17(3):674-683. doi: 10.1177/1534735418762537. Epub 2018 Apr 2.

17.

Lucidumol D, a new lanostane-type triterpene from fruiting bodies of Reishi (Ganoderma lingzhi).

Satria D, Amen Y, Niwa Y, Ashour A, Allam AE, Shimizu K.

Nat Prod Res. 2019 Jan;33(2):189-195. doi: 10.1080/14786419.2018.1440229. Epub 2018 Feb 19.

PMID:
29457741
18.

Ganoderma lucidum polysaccharide enhances radiosensitivity of hepatocellular carcinoma cell line HepG2 through Akt signaling pathway.

Yu Y, Qian L, Du N, Liu Y, Zhao X, Zhang X.

Exp Ther Med. 2017 Dec;14(6):5903-5907. doi: 10.3892/etm.2017.5340. Epub 2017 Oct 18.

19.

Apoptosis induction of colorectal cancer cells HTL-9 in vitro by the transformed products of soybean isoflavones by Ganoderma lucidum.

Cui ML, Yang HY, He GQ.

J Zhejiang Univ Sci B. 2017 Dec.;18(12):1101-1112. doi: 10.1631/jzus.B1700189.

20.

Ganoderma lucidum polysaccharide inhibits prostate cancer cell migration via the protein arginine methyltransferase 6 signaling pathway.

Zhao X, Zhou D, Liu Y, Li C, Zhao X, Li Y, Li W.

Mol Med Rep. 2018 Jan;17(1):147-157. doi: 10.3892/mmr.2017.7904. Epub 2017 Oct 26.

Supplemental Content

Loading ...
Support Center